Literature DB >> 6702394

Low plasma fibronectin indicates septicaemia in major burns.

B Brodin, H von Schenck, B Schildt, S O Liljedahl.   

Abstract

Plasma fibronectin was measured by laser nephelometry in 23 patients with 20--85% burns. Control measurements were made in 118 healthy blood donors aged 18--60 years. The reference level was significantly higher in the 72 males (mean +/- SD = 377 +/- 70 mg/l) than in the 46 females (327 +/- 55 mg/l). In the burn-injured patients the mean fibronectin concentration was significantly lower than the reference values for one week after the injury. All the patients had low concentrations, about 70% of their respective reference means, in the first 24 hours after the injury. When burn treatment was successful, the fibronectin thereafter increased, gradually exceeding the reference level. Patients with septic complications, by contrast, showed further reduction of fibronectin levels. In the patients who died, the fibronectin concentration 6--10 days after burn injury was significantly less than in the patients who survived. On the basis of these results, repeated analysis of plasma fibronectin in the early postburn period is recommended. Persistent fibronectin deficiency then is an indicator of imminent septicaemia, vital organ failure and risk of fatal outcome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6702394

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  7 in total

1.  Plasma fibronectin and complement following infusion of colloidal solutions after spinal anaesthesia.

Authors:  J M Vedrinne; J P Hoen; D Bussery; C Veyssere; M Richard; J Motin
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Plasma fibronectin and the critically ill.

Authors:  J K Czop
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

3.  Regulation of fibronectin synthesis by interleukin-1 and interleukin-6 in rat hepatocytes.

Authors:  T Hagiwara; H Suzuki; I Kono; H Kashiwagi; Y Akiyama; K Onozaki
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

Review 4.  Fibronectin and the critically ill patient: current status.

Authors:  T M Saba; J L Kiener; J M Holman
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

5.  Plasma fibronectin concentrations in patients with HIV infection and visceral leishmaniasis.

Authors:  A Rodríguez-Cuartero; J Nuñez-Carrill; A Salas-Galán; M A Rodríguez-Rodríguez
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

6.  Terminal Maturation of Orthochromatic Erythroblasts Is Impaired in Burn Patients.

Authors:  Shirin Hasan; Michael J Mosier; Peggie Conrad; Andrea Szilagyi; Richard L Gamelli; Kuzhali Muthumalaiappan
Journal:  J Burn Care Res       Date:  2018-02-20       Impact factor: 1.845

7.  Changes in plasma fibronectin isoform levels predict distinct clinical outcomes in critically ill patients.

Authors:  John H Peters; Mark N Grote; Nancy E Lane; Richard J Maunder
Journal:  Biomark Insights       Date:  2011-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.